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 Abstract. Hypericum perforatum or St. John's wort is a medicinal plant with a long history of 
use in traditional medicine all over. Because of both Romanian and European Pharmacopoeia accept 
as officinal only H. perforatum L, the aim of the present study is to compare the botanical and 
physiochemical characteristics of the H. perforatum and H. maculatum. The experiment was carried 
out on 40 white NMRI male mice, for 14 days long; each animal received 106 ascitic cells i.p., in the 
first day. Animals were divided in four equal experimental groups, First group (HM) received daily 
500 mg/kg b.w. H. maculatum, the second group (HP) 500 mg/kg b.w. H. perforatum, the control 
group alcohol 70°, and the last group Doxorubicin 0.1 mg/animal in day 6 of experiment.  
The body weight varied in insignificant manner, however HM, seems to provided some 
protective effect as compared to control and even to D group. The viable cell concentration of EAC, as 
expected, was the lowest in D group (highly statistical significant), followed by HM, HP was less 
effective. The average life span was higher in D group, but HM seems to provide also some protective 
effect, however the survival rate varied insignificant among the groups in study. HM provides some 
protection against hematological side effects of EAC, mainly at MCH and MCHC levels.  
In conclusion, both extracts provides some promising antiproliferative effects, despite the fact 
that not all experimental data are statistically covered, therefore future research should be done. 
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INTRODUCTION 
 
 Hypericum perforatum or St. John's wort is a medicinal plant with a long history of 
use in traditional medicine all over Europe. In Romania’s spontaneous flora there are 
mentioned 12 species of Hypericum: one is cultivated (H. calycinum L.) and two are very rare 
(H. rumeliacum Boiss. and H. rochelii ) (Bisset N., Wichtl M. 1994). The most widely spread 
species are H. perforatum L. (in the hills region) and H. maculatum Crantz. (in the mountain 
regions). To obtain the medicinal drug Hyperici herb it is possible to harvest in the mountain 
regions the aerial parts of H. maculatum too.  
Because of both Romanian Pharmacopoeia (R.Ph. 1993) and European Pharmacopoeia 
(E. Ph. 2008) accept as officinal only H. perforatum L, the aim of the present study is to 
compare the botanical and physiochemical characteristics of the H. perforatum and H. 
maculatum, the most widely spread species from Romania.  
Aerial parts of Hypericum species contain the following active substances: 
naphtodiantrons 0.1-0.5% (hypericin, pseudohypericin and their isomers), flavonoids 4-5% 
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(hyperoside, rutoside, quercitroside, biapigenin), tannins 10-20%, hyperforin, 
proanthocyanins, caffeic acid derivatives, xanthons, essential oil 0.1-1% etc. 
Ehrlich ascitic carcinoma (EAC) is a convenient model for investigation of tumour side 
effects, but, also, for investigation of anti tumor immune response (Olinescu, 1992). EAC, 
induce significant plasma biochemical changes, including antioxidant systems (Marcus, et. al. 
1998); transplantable tumors have been successfully used to prove the antioxidant and anti 
malignant properties for beta carotene (Marcus, et. al. 1999). (Muresan et. al. 2006), used 
Ehrlich ascitic carcinoma to prove the anti malignant and anti oxidant properties of grape seed 
extract (also a product rich in polyphenolsic compounds), alone and together to doxorubicin. 
Sevastre B., et al.2008). 
 
MATERIAL AND METHODS 
 
Plant materials: the aerial parts of H. perforatum were harvested from Chiribiş (Bihor 
county) and the aerial parts of H. maculatum were harvested from Ciucea (Cluj county) in the 
blossom period, in june 2008. The vegetal products were dried and grounded to a fine powder 
(sieve VI  - R. Ph. 1993). 
Preparation of tinctures: 10g of powdered aerial parts of vegetal product were 
extracted with 100g of ethanol 70° at room temperature, as described in Romanian 
Pharmacopoeia Xth Edition. 
In E. Ph. 2008 it is mentioned as minimum content in total hypericins for the 
medicinal drug Hyperici herb 0.08%, determined by a spectrophotometer method and a 
qualitative analysis by TLC in order to identify the flavonoids and hypericin. 
To prevent toxic effect of the alcohol, often more toxic than plant compounds 
dissolved in it, alcoholic solution was maintained in a water bath until half of the content 
evaporates, than filed with water to the initial volume. The aqueous solution was 
administrated in the same day in order to prevent the bacterial and fungus contamination. 
The animals were caged in groups of 10 per cage, at controlled temperature of 21-22ºC, 
humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard lab 
chow and water were freely available. The permission for the animal tests and experiments 
has been given by the Bioethical Board of the Faculty of Veterinary Medicine Cluj-Napoca, 
decision no. 2/19.01.2009. 
For assessing the antiproliferative effect, the experiment was carried out on 40 white 
NMRI male mice, 34.5±3.5g body weight; each animal received 106 ascitic cells intra 
peritoneally, in the first day. The experiment last for 14 days, in the Department of 
Pathophysiology, University of Agricultural Science and Veterinary Medicine Cluj-Napoca. 
Ehrlich ascitic carcinoma (EAC) was a generous gift from the Oncology Institute “I. 
Chiricuta” Cluj Napoca.  
Animals were divided in four equal experimental groups; all inoculated with Ehrlich 
ascitic carcinoma. Body weight was measured at the beginning, in the middle and at the end 
of experiment. 
First group (HM) received daily 0.5 ml (500 mg) Hypericum maculatum 1:10 in ethylic 
alcohol 70° p.o. The second group (HP) received daily 0.5 ml (500 mg) Hypericum 
perforatum 1:10 in ethylic alcohol 70° p.o. The control group received 0.5 ml alcohol 70°, 
p.o. and the last group received an intra peritoneal injection with Doxorubicin 0.1 mg/animal 
in day 6 of experiment. 
The solutions were administrated orally by using a lubricated needle catheter.  
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In the end the blood was harvested from the retro orbitary sinus under diethyl ether 
anesthesia and the euthanasia was made by prolonged ether narcosis. Total amount of ascitic 
fluid was measured, and viable tumor cell concentration was counted in a Burker camera 
(liquid diluted 1:100). Cell viability was assessed by tripan blue staining (Olinescu, 1992). 
The average survival time, was assessed for each group in study. 
The data were expressed as the mean and standard deviation. T Student multiple range 
test from Excel Windows Software was used to assess the differences among groups. 
Differences at p<0.05 and p<0.01 were considered significant and respectively distinct 
significant. 
 
RESULTS AND DISCUSSIONS 
 
Body weight was decreased in both HM group and D group, but statistical significance 
has been found only for D group.  
 
 
 
 
 
The average life span revealed a longer survival time for HM group as compared to HP 
group and ALC group, but shorter than D group; however, no statistical significance among 
groups has been found (Fig 2)  
Viable EAC cell concentration decreased in HM group without statistical significance 
comparative to D group (Fig. 3) 
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Fig. 1 Body weight: 
 A=first body weight/group, B= second body weight/group, C= last body weight/group 
            * = statistically significant at p<0.05 
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Fig.2 Average of life period. 
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Fig. 3 Total Erlich ascitic cell count 
           * *= statistically distinct significant at p<0.01 
 
Hematology. MCH and MCHC were significantly decreased in HM group comparative 
to the ALC group, but it was no significant as compared to D group. PLT were highly 
increased in D group comparative to ALC group. The higher values were found in HP group 
but they were not significant because of increased standard deviation. (Table 1) 
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Table 1. 
Effect of the HP and HM tinctures. 
0.5ml (500 mg)/kg body weight HP, HM, Doxorubicin 0.1mg/animal 
Parameters EAC+ Alcohol EAC+HP EAC+HM EAC+ Doxorubicin 
WBC x109/l 54.83±29.1 81.86±11.09 66.18±34.08 84.83±48.07 
RBC x1012/l 7.50±1.19 7.42±1.16 7.63±0.91 7.32±1.44 
HGB g/l 21.01±2.27 20.18±1.67 19.71±2.15 19.97±3.06 
HCT % 34.19±3.26 35.41±4.87 35.38±4.04 34.14±6.49 
MCV fl 46.16±4.30 47.80±3.11 46.5±1.97 46.71±2.87 
MCH pg 28.26±2.38 27.54±3.16 25.93±2.36*d 28.9±11.19 
MCHC g/l 61.56±4.02 57.32±3.94 55.91±4.55*d 45.44±20.70 
PLT x109/l 402±146.79 617.4±217.34 473.6±84.09 593.85±112.48*f 
MPV fl 6.96±0.77 6.8±0.26 8.83±1.71 9.62±2.19 
PDWc % 33.46±3.23 31.88±1.51 34.01±2.56 35.22±3.02*c 
a= T test HP/ALC, b= T test HP/HM, c= T test HP/D, d= T test HM/ALC, e= T test HM/D, f= T test D/ALC 
* = statistically significant at p<0.05 
 
CONCLUSIONS 
 
The body weight varied in insignificant manner, however Hypericum maculatum (HM), 
seems to provided some protective effect as compared to control and even to Doxorubicin 
group (D), it seems to be more active than Hypericum perforatum (HP). The viable cell 
concentration of Ehrlich Ascitic Carcinoma (EAC), as expected, was the lowest in D group 
(highly statistical significant), followed by HM, HP was less effective.  
The average life span was higher in D group, but HM seems to provide also some 
protective effect, however the survival rate varied insignificant among the groups in study. 
HM provides some protection against hematological side effects of EAC, mainly at MCH and 
MCHC levels.  
In conclusion, both extracts provides some promising antiproliferative effects, despite 
the fact that not all experimental data are statistically covered, therefore future research 
should be done.  
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